Service advice and planning
39 results
Applied filters
Supervision of aseptic preparation under Section 10 exemption
17 November 2025The section 10 exemption from the Medicines Act permits aseptic preparation of medicines under the supervision of a pharmacist.
Submitting iQAAPS Quality Indicators (QIs)
14 August 2025Guidance for Accountable Pharmacists on submission of quality indicators (QI) for NHS Section 10 aseptic preparation activities using the iQAAPS system.
Supply and administration of medicines by staff group (P to Z)
1 April 2026Different staff groups have different permissions with respect to medicines supply and administration and it is important to ensure legislation is followed.
Exagamglogene autotemcel (Casgevy®)
13 February 2026This document highlights key areas where Chief Pharmacists should focus pharmaceutical expertise prior to implementation of exagamglogene autotemcel.
Ex-vivo GMO gene therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmacy expertise prior to an organisation implementing ex-vivo genetically modified organism (GMO) gene therapy.
In-vivo GMO gene therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmacy expertise prior to an organisation implementing in-vivo genetically modified organism (GMO) gene therapy.
Legal mechanisms to supply and administer medicines to individuals
1 April 2026The main legal mechanisms used to supply and/or administer medicines are explained and considerations suggested for the most appropriate option(s)
Tissue engineered products
13 February 2026This document outlines key areas for focus of pharmaceutical expertise prior to an organisation implementing tissue engineered products.
Monitoring and auditing clinical trials
29 April 2026An overview of the Sponsor Pharmacy's responsibilities for monitoring and auditing clinical trial locations.
Closing clinical trials
29 April 2026Sponsor pharmacy responsibilities during trial closure and the final monitoring visit